Wellness Genomics Market Report 2025 – For Strategy Officers And Market Intelligence Teams

June 20, 2025 08:05 PM AEST | By EIN Presswire
 Wellness Genomics Market Report 2025 – For Strategy Officers And Market Intelligence Teams
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- It's been observed that the wellness genomics market has seen quite a spike in its growth rate in recent years. The market is expected to grow from $4.99 billion in 2024 to $5.68 billion in 2025, with a compound annual growth rate CAGR of 13.8%. Factors such as an increase in chronic disease prevalence, growing consumer health awareness, rising demand for personalized health, focuses on preventive healthcare, and growing direct-to-consumer genomics, have significantly attributed to this growth in the preceding period.

What Is The Projected Future Growth Of The Wellness Genomics Market Size?
The next few years are anticipated to yield even more rapid growth for the wellness genomics market. By 2029, it is projected to have a market value of $9.46 billion, driven by a CAGR of 13.6%. This forthcoming growth can be attributed to several reasons, including the increasing affordability of genetic testing, more investments in healthcare, growing interest in personalized nutrition, rising disposable incomes, a growing geriatric population, and a rising demand for personalized health and wellness.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24430&type=smp

What Are The Key Drivers Propelling The Growth Of The Wellness Genomics Market?
A major driving force for the growth of the wellness genomics market is the increasing demand for personalized medicine. This medical approach tailors treatment and care to an individual's unique genetic makeup, lifestyle, and health conditions for more precise and effective outcomes. The ability of wellness genomics to reveal unique genetic insights that tailor lifestyle and preventive health strategies to each individual’s unique biological makeup makes it an important facilitator of personalized medicine.

What Key Player Strategies Are Driving The Wellness Genomics Market?
Major companies operating in the wellness genomics market include Danaher Corporation, Eurofins Scientific SE, BGI Group, Agilent Technologies Inc., Bio-Rad Laboratories Inc., 23andMe Holding Co., Color Health Inc., Variantyx Inc., Segterra Inc., Dante Labs Inc., among others. They have been pivotal in shaping the market dynamics.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/wellness-genomics-global-market-report

What Are The Emerging Trends In The Wellness Genomics Market?
Many of these firms are focusing on developing innovative solutions, such as personalized genomics platforms, to provide tailored health insights and lifestyle recommendations based on an individual’s genetic profile. This is an emerging trend that's set to significantly influence the market dynamics going forward.

How Is The Wellness Genomics Market Segmented?
Peering deep into the report, the wellness genomics market is segmented by Type Predictive Testing, Consumer Genomics, Other Types; by Setting Type Direct-To Consumer DTC, Professional; and by Application Breast And Ovarian Cancer Screening, Diabetic Screening And Monitoring, and others. Other types include Epigenetic Testing, Microbiome And Gut Health Genomics, and Pharmacogenomics For Lifestyle Drugs.

What Are The Regional Insights In The Wellness Genomics Market?
In terms of regional analysis, North America held the largest share in the wellness genomics market in 2024. However, Asia-Pacific is expected to be the fastest-growing region in the forecast period.

Browse through more similar reports by The Business Research Company:
Genomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

The Business Research Company, with over 15000+ reports from 27 industries covering 60+ geographies, is a trusted name for providing comprehensive, data-rich research and insights. The company prides itself on its 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders. TBRCS is all set to provide you with the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.